SterRx Recalls 240 Lots of 12 Products
Equipment and process issues could lead to a lack of sterility.
SterRx is recalling about 240 lots of 12 different products. The recall is being made because of due equipment and process issues that could lead to a lack of sterility. To date, SterRx has not received reports of adverse events associated.
These lots were distributed between December 2020 and October 2021.
The products impacted include:
- 1mg/mL Midazolam in 0.9% Sodium Chloride
- Fentanyl in 0.9% Sodium Chloride
- 1mg/mL Morphine Sulfate in 0.9% Sodium Chloride
- 1mg/mL Morphine Sulfate in 5% Dextrose
- 125mg Diltiazem HCL in 0.7% Sodium Chloride
- 125mg Diltiazem HCL in 5% Dextrose
- Norepinephrine in 0.9% Sodium Chloride
- Norepinephrine in 5% Dextrose
- Epinephrine in 0.9% Sodium Chloride
- Phenylephrine in 0.9% Sodium Chloride
- 150mEq Sodium Bicarbonate in 5% Dextrose
- 200mg Succinylcholine Chloride in 0.9% Sodium Chloride
Those with questions should call (518) 324-7983 or email Recall@sterrx.com.
FDA Issues Complete Response for High-Dose Opioid Rescue Med
July 16th 2024OX124 is a nasal spray provides rapid absorption of naloxone for patients experiencing an opioid overdose. The FDA would like to see additional technical data, as well as data on whether patients can correctly use the device.
Read More
